Targeting the CD74-MHC II axis with allergen-specific immunotherapy ameliorates pollen-induced allergic asthma.
- DOI
- 10.1016/j.waojou.2026.101478
- Published
- 2026 Nov
- Container
- The World Allergy Organization journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.waojou.2026.101478,
title = {Targeting the CD74-MHC II axis with allergen-specific immunotherapy ameliorates pollen-induced allergic asthma.},
author = {Ming W and Zhou Y and Liu T and Wang H and Wang X and Ma T},
year = {2026},
journal = {The World Allergy Organization journal},
doi = {10.1016/j.waojou.2026.101478},
url = {https://doi.org/10.1016/j.waojou.2026.101478}
}RIS
TY - JOUR TI - Targeting the CD74-MHC II axis with allergen-specific immunotherapy ameliorates pollen-induced allergic asthma. AU - Ming W AU - Zhou Y AU - Liu T AU - Wang H AU - Wang X AU - Ma T PY - 2026 JO - The World Allergy Organization journal DO - 10.1016/j.waojou.2026.101478 UR - https://doi.org/10.1016/j.waojou.2026.101478 ER -
APA
W, M., Y, Z., T, L., H, W., X, W., & T, M. (2026). Targeting the CD74-MHC II axis with allergen-specific immunotherapy ameliorates pollen-induced allergic asthma.. The World Allergy Organization journal. https://doi.org/10.1016/j.waojou.2026.101478
Source records
- pubmed · retrieved 2026-11-10T14:56:58.951Z